Volumetric Markers in Bulimia Nervosa: A Multi-site Longitudinal Study using ComBat Harmonization

Poster No:

437 

Submission Type:

Abstract Submission 

Authors:

Ruri Katsunuma1, Tsunehiko Takamura1, Yusuke Sudo2, Rio Kamashita2, Eiji Shimizu2, Koji Matsumoto3, Keiko Ino1, Shin Fukudo4, Yasuhiro Sato4, Nobuhiro Nohara5, Kazuhiro Yoshiuchi6, Masanori Isobe7, Naoki Kodama8, Masatoshi Takahashi8, Satoru Ide9, Kazumasa Okada10, Kazufumi Yoshihara11,12, Shu Takakura12, Motoharu Gondo12, Yoshiya Moriguchi1, Yoshiyuki Hirano2, Atsushi Sekiguchi1

Institutions:

1Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry, Tokyo, Japan, 2Research Center for Child Mental Development, Chiba University, Chiba, Japan, 3Department of Radiology, Chiba University Hospital, Chiba, Japan, 4Department of Psychosomatic Medicine, Tohoku University Hospital, Sendai, Japan, 5Department of Psychosomatic Medicine, The University of Tokyo Hospital, Tokyo, Japan, 6Dept. of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The Univ. of Tokyo, Tokyo, Japan, 7Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 8Div. of Psychosomatic Medicine, Dept. of Neurology, Univ. of Occupational and Environmental Health, Kitakyushu, Japan, 9Department of Radiology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan, 10Department of Neurology, University of Occupational and Environmental Health School of Medicine, Kitakyushu, Japan, 11Center for Health Sciences and Counseling, Kyushu University, Fukuoka, Japan, 12Department of Psychosomatic Medicine, Kyushu University Hospital, Fukuoka, Japan

First Author:

Ruri Katsunuma  
Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry
Tokyo, Japan

Co-Author(s):

Tsunehiko Takamura  
Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry
Tokyo, Japan
Yusuke Sudo  
Research Center for Child Mental Development, Chiba University
Chiba, Japan
Rio Kamashita  
Research Center for Child Mental Development, Chiba University
Chiba, Japan
Eiji Shimizu  
Research Center for Child Mental Development, Chiba University
Chiba, Japan
Koji Matsumoto  
Department of Radiology, Chiba University Hospital
Chiba, Japan
Keiko Ino  
Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry
Tokyo, Japan
Shin Fukudo  
Department of Psychosomatic Medicine, Tohoku University Hospital
Sendai, Japan
Yasuhiro Sato  
Department of Psychosomatic Medicine, Tohoku University Hospital
Sendai, Japan
Nobuhiro Nohara  
Department of Psychosomatic Medicine, The University of Tokyo Hospital
Tokyo, Japan
Kazuhiro Yoshiuchi  
Dept. of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The Univ. of Tokyo
Tokyo, Japan
Masanori Isobe  
Department of Psychiatry, Graduate School of Medicine, Kyoto University
Kyoto, Japan
Naoki Kodama  
Div. of Psychosomatic Medicine, Dept. of Neurology, Univ. of Occupational and Environmental Health
Kitakyushu, Japan
Masatoshi Takahashi  
Div. of Psychosomatic Medicine, Dept. of Neurology, Univ. of Occupational and Environmental Health
Kitakyushu, Japan
Satoru Ide  
Department of Radiology, University of Occupational and Environmental Health School of Medicine
Kitakyushu, Japan
Kazumasa Okada  
Department of Neurology, University of Occupational and Environmental Health School of Medicine
Kitakyushu, Japan
Kazufumi Yoshihara  
Center for Health Sciences and Counseling, Kyushu University|Department of Psychosomatic Medicine, Kyushu University Hospital
Fukuoka, Japan|Fukuoka, Japan
Shu Takakura  
Department of Psychosomatic Medicine, Kyushu University Hospital
Fukuoka, Japan
Motoharu Gondo  
Department of Psychosomatic Medicine, Kyushu University Hospital
Fukuoka, Japan
Yoshiya Moriguchi  
Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry
Tokyo, Japan
Yoshiyuki Hirano  
Research Center for Child Mental Development, Chiba University
Chiba, Japan
Atsushi Sekiguchi  
Department of Behavioral Medicine, NIMH, National Center of Neurology and Psychiatry
Tokyo, Japan

Introduction:

Bulimia Nervosa (BN) is an eating disorder characterized by binge eating, purging or fasting, and concerns related to body shape and weight (American Psychiatric Association, 2022). Cognitive-behavioral therapy (CBT) is the first-line treatment for BN, yet high dropout rates and variable efficacy emphasize the need for a deeper understanding of the mechanisms underlying treatment response. Therefore, identifying neurobiological markers that predict treatment response or track therapeutic changes could enhance personalized interventions. However, recruiting sufficient sample sizes at single sites is challenging due to the nature of BN, as many individuals do not seek consistent treatment. To address this gap, we conducted a multi-site, observational cohort study utilizing CBT and applied inter-scanner harmonization to remove non-biological variability. The goal of this study was to identify predictive and treatment response markers of brain volume changes, focusing on regions associated with interoception, somatosensory processing, and cerebellar function, given their integral roles in bodily signal integration and the regulation of eating behavior.

Methods:

The study involved female patients with BN who underwent CBT. MRI data were collected from six facilities using different MRI scanners. Each participant underwent T1-weighted MRI scans before (pre) and after (post) treatment. To address inter-scanner variability, preprocessing included standardization, smoothing (8 mm FWHM), and voxel-based ComBat Harmonization (Fortin et al., 2018; Maikusa et al., 2021). To assess eating disorder severity, Eating Disorder Examination Questionnaire (EDE-Q), a validated self-report measure capturing core symptoms of eating disorder (Aardoom et al., 2012) was used. Regions of Interest were selected a priori for each marker, based on the prior neural anatomical evidence of BN (e.g., Donnelly et al., 2018).
Two analyses were conducted:
1. Predictive marker analysis:
Data from 37 patients (mean±SD age = 33.48±9.77 years) were used to investigate whether baseline brain volume predicted improvements in EDE-Q global scores (Post-Pre). Anatomical masks for the inferior parietal lobe, postcentral gyrus, and insula were used to examine interoceptive and somatosensory processing regions. Small Volume Correction (SVC) was applied.
2. Treatment response marker analysis:
Data from 41 patients (mean±SD age = 33.51±9.64 years) were used to evaluate correlations between brain volume changes (Post-Pre) and EDE-Q improvements. Given the emerging role of the cerebellum in eating behavior regulation, a cerebellar anatomical mask was employed, and SVC was applied.
Both analyses included EDE-Q scores, age, and total brain volume as covariates. Statistical analyses were conducted using SPM12 with a significance threshold of p < 0.05 (FWE-corrected).

Results:

In the predictive marker analysis, greater baseline brain volume in the left inferior parietal region (MNI x, y, z: −42, −34, 48) was significantly associated with greater reductions in EDE-Q scores post-treatment (p=0.039, FWE-corrected). This finding suggests the potential of this region as a marker of treatment responsiveness. In the treatment response marker analysis, significant associations were observed in the cerebellum (lobule VI/declive) (x, y, z: −30, −64, −20), where reductions in cerebellar volume correlated with higher treatment efficacy (p=0.048, FWE-corrected). Patients with greater cerebellar volume reductions exhibited more substantial symptom improvements, highlighting cerebellar involvement in therapeutic adaptation.

Conclusions:

This study identifies the left inferior parietal region as a predictive marker and the cerebellum as a marker of therapeutic plasticity in BN. These findings provide neurobiological evidence supporting the efficacy of CBT and provide new insights into biomarkers for personalized interventions in BN treatment.

Disorders of the Nervous System:

Psychiatric (eg. Depression, Anxiety, Schizophrenia) 1

Learning and Memory:

Neural Plasticity and Recovery of Function 2

Neuroanatomy, Physiology, Metabolism and Neurotransmission:

Anatomy and Functional Systems

Novel Imaging Acquisition Methods:

Imaging Methods Other

Perception, Attention and Motor Behavior:

Perception: Tactile/Somatosensory

Keywords:

Acquisition
Behavioral Therapy
Cerebellum
Eating Disorders
Morphometrics
MRI
Plasticity
Psychiatric Disorders
Somatosensory
Treatment

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I do not want to participate in the reproducibility challenge.

Please indicate below if your study was a "resting state" or "task-activation” study.

Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Patients

Was this research conducted in the United States?

No

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

Not applicable

Please indicate which methods were used in your research:

Structural MRI
Behavior

For human MRI, what field strength scanner do you use?

3.0T

Which processing packages did you use for your study?

SPM

Provide references using APA citation style.

References
Aardoom, J. et al. (2012). Norms and discriminative validity of the Eating Disorder Examination Questionnaire (EDE-Q). Eating behaviors, 13(4), 305-309.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).
Donnelly, B. (2018). Neuroimaging in bulimia nervosa and binge eating disorder: a systematic review. Journal of Eating Disorders, 6(3), 3.
Fortin, J. et al. (2018). Harmonization of cortical thickness measurements across scanners and sites. NeuroImage, Volume 167, 104-120.
Maikusa, N. et al. (2021). Brain age estimation using support vector regression and harmonization across scanner and site. Medical Imaging Technology, 2021;39:171-5.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No